A more recent study suggested that patients with germline BRCA1/2mut ER+ tumours had a 2.3 times higher risk of disease recurrence and 3.4 times higher risk of breast cancer-related deaths compared to non-carriers [61]. Here, BRCA1 is linked to neoplasm.